SAD Study in Patients With Parkinson's Disease and Motor Fluctuations (NCT07422675)
A Randomized, Placebo-Controlled, Single Ascending Dose (SAD) Study to Assess the Safety, Tolerability, and Pharmacokinetics of SER-252 in Patients With Parkinson's Disease and Motor Fluctuations
🩺 Plain-English Summary (8th-Grade Level)
This is a randomized, placebo-controlled, single ascending dose (SAD) study of SER-252 in participants with Parkinson's Disease (PD) and motor fluctuations.
Who can join: Review the eligibility criteria below.
Location: Rocky Mountain Clinical Research — Englewood, Colorado
Age range: 40 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Rocky Mountain Clinical Research — Englewood, Colorado
- Velocity Clinical Research — Hallandale, Florida
- K2 Medical Research LLC — Maitland, Florida
- Quest Research Institute — Farmington Hills, Michigan
- CMAX — Adelaide, South Australia
- Monash — Melbourne, Victoria
📞 Contact the Study Coordinator
Phone: (256) 783-7649
Email: rmoreadith@serinatherapeutics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in PARKINSON DISEASE (Disorder)
- Autologous Bone Marrow Aspirate (IV) and Bone Marrow Concentrate (Intranasal) for Parkinson's Disease and Parkinson-Plus Syndromes (SPARC-PD) — Boulder, Colorado
- Prescriptive Infusion Algorithm (PIA) — Cleveland, Ohio
- SwallowFIT Study in Parkinson's Disease — San Antonio, Texas
- Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation — Richardson, Texas
- Multicontext Approach for Cognitive Function in Parkinson Disease — St Louis, Missouri
- Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms — Cleveland, Ohio
Explore by condition: All PARKINSON DISEASE (Disorder) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.